Nurix Therapeutics, Inc. (NRIX) Financials

NRIX Assets vs Liabilities
DateAssetsLiabilities
May 31, 2026 535.5 million 132.9 million
Feb. 28, 2026 636.1 million 155.2 million
Nov. 30, 2025 688.1 million 149.4 million
Aug. 31, 2025 522.5 million 150.2 million

NRIX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
May 31, 2026 -98.5 million 11.4 million
Feb. 28, 2026 -73.0 million 9.4 million
Nov. 30, 2025 -73.0 million 9.1 million
Aug. 31, 2025 -60.1 million 9.8 million

NRIX Net Income

No data available :(

NRIX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
May 31, 2026 443.5 million 54.9 million 58.1 million
Feb. 28, 2026 540.7 million - 58.7 million
Nov. 30, 2025 592.9 million - 55.7 million
Aug. 31, 2025 428.8 million - 56.5 million

NRIX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
May 31, 2026 ?
Feb. 28, 2026 110.1 million
Nov. 30, 2025 95.1 million
Aug. 31, 2025 84.2 million

NRIX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
May 31, 2026 1.9 million 87.7 million 15.6 million -
Feb. 28, 2026 1.0 million 84.1 million 14.6 million -
Nov. 30, 2025 5.1 million 80.9 million 13.6 million -
Aug. 31, 2025 2.7 million 86.1 million 13.2 million -

NRIX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
May 31, 2026 9.0 million 3.9 million
Feb. 28, 2026 6.3 million 84.1 million
Nov. 30, 2025 13.6 million 4.6 million
Aug. 31, 2025 7.9 million 5.0 million

NRIX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

NRIX

Price: $23.48

52 week price:
8.20
25.08

Earnings Per Share: -3.22 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 161700

Market Capitalization: 2.5 billion

Links: